Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
262.67
-20.62 (-7.28%)
At close: Feb 19, 2026, 4:00 PM EST
259.98
-2.69 (-1.02%)
After-hours: Feb 19, 2026, 5:48 PM EST
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $7.68 billion as of February 19, 2026. Its market cap has increased by 67.13% in one year.
Market Cap
7.68B
Enterprise Value
6.72B
1-Year Change
67.13%
Ranking
Category
Stock Price
$262.67
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $7.68B, an increase of 8,209.98%. That is a compound annual growth rate of 69.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 8.41B | 17.70% |
| Dec 31, 2025 | 7.15B | 58.67% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 9.31B |
| Bio-Techne | 9.28B |
| Praxis Precision Medicines | 9.12B |
| Arrowhead Pharmaceuticals | 9.02B |
| Halozyme Therapeutics | 8.61B |
| ImmunityBio | 8.41B |
| Cytokinetics | 8.19B |
| Vaxcyte | 8.06B |